U.S. wrestling athlete Bradley accepts sanction for anti-doping rule violation

<< Back to Articles

Colorado Springs, Colo. (September 6, 2013)- USADA announced today that Dominique Bradley of Columbia, Mo., an athlete in the sport of Wrestling, has tested positive for a prohibited substance and accepted an eight-month suspension for his doping offense. 

Bradley, 24, tested positive for Methylhexaneamine as the result of an in-competition urine sample collected on April 19, 2013 at the U.S. Open in Las Vegas, Nev. Stimulants are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Federation of Associated Wrestling Styles (“FILA”) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List. Methylhexaneamine is classified as a Specified Substance, and therefore the presence of that substance in an athlete’s sample can result in a reduced sanction.

Bradley’s eight-month period of ineligibility began on April 19, 2013, the date his sample was collected. As a result of the violation, Bradley has been disqualified from all competitive results achieved on and subsequent to April 19, 2013, including forfeiture of any medals, points, and prizes. 

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.